Sign in

CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Aura Biosciences, Inc.

Sign in to watch
Ticker
AURA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320271970
Phone
(617)500-8864
Business address
80 GUEST STREET, BOSTON, MA, 02135
  1. 4 Derivatives Options or other derivatives
  2. 8-K Event Shareholder vote results
  3. 4 Open-market buy Director bought 50,000 shares at an average $14.33 ($716,300)
  4. 8-K Event Regulation FD disclosure
  5. 8-K Event Material agreement · New debt or obligation
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. DEFA14A Proxy Proxy Materials
  9. DEF 14A Proxy Proxy Statement
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G Stake Amended Statement of Ownership
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. SC 13G Stake Amended Statement of Ownership
  20. SC 13G Stake Amended Statement of Ownership

Page 16 of 20 · 383 filings